| Filed On | Filing |
|---|---|
| 16 Oct 2026 |
Form 3: Comas Daniel L, Director
Holds 18,804 shares of Common Stock |
| 16 Oct 2026 |
Form 3: Hershberg Robert, Director
Holds 0 shares of No securities are beneficially owned |
| 02 Oct 2026 |
Form 3: Muppaneni Shashanka, SVP, Chief Strategy Officer
Holds 5,901 shares of Common Stock |
| 02 Oct 2026 |
Form 3: Moler Heathre T, SVP, Chief HR Officer
Holds 5,356 shares of Common Stock |
| 02 Mar 2026 |
Form 3: Gugino Matthew E, EVP & Chief Financial Officer
Holds 7,644 shares of Common Stock |
| 27 Aug 2025 |
Form 3: Leiken Jonathan, SVP- General Counsel
Holds 0 shares of No securities are beneficially owned |
| 01 Jul 2025 |
Form 3: Milosevich Gregory M, Executive Vice President
Holds 4,455 shares of Common Stock |
| 24 Feb 2025 |
Form 3: Lamanna Charles W, Director
Holds 0 shares of No securities are beneficially owned |
| 27 Sep 2024 |
Form 3: Gray R Bradley, SVP Strategic Development
Holds 0 shares of No securities are beneficially owned |
| 08 Jul 2024 |
Form 3: Sawyer Montgomery Julie A, Executive Vice President
Holds 5,872 shares of Common Stock |
| 04 Jan 2024 |
Form 3: Riley Christopher Paul, Executive Vice President
Holds 13,073 shares of Common Stock |
| 11 Sep 2023 |
Form 3: Danaher Corp /DE/, 10% owner · Veralto Corporation
Holds 100 shares of Common Stock |
| 29 Jun 2022 |
Form 3: Dewan Feroz, Director
Holds 0 shares of No securities are beneficially owned |
| 01 Apr 2022 |
Form 3: Couchara Georgeann, SVP, Human Resources
Holds 5,195 shares of Common Stock |
| 06 Jan 2022 |
Form 3: Bouda Christopher, VP - Chief Accounting Officer
Holds 5,178 shares of Common Stock |
| 06 Jan 2022 |
Form 3: Bouda Christopher, VP - Chief Accounting Officer
Holds 5,178 shares of Common Stock |
| 17 Jun 2021 |
Form 3: Danaher Corp /DE/, 10% owner and 1 other · Telesis Bio Inc.
Holds 2,294,157 shares of Common Stock |
| 18 May 2021 |
Form 3: Sanders A Shane, Director
No securities owned |
| 05 Jan 2021 |
Form 3: Honeycutt Jennifer, Executive Vice President
Holds 8,933 shares of Common Stock |
| 21 Dec 2020 |
Form 3: Gutierrez-Ramos Jose-Carlos, SVP, Chief Scientific Officer
No securities owned |
Loading...
